Cannabis Global, Inc. - Understand $cbgl stock

$CBGL Market Cap: $85.23 Thousand

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$2.620M

TTM

Gross Margin

-2.19%

TTM

Net Earnings

-$3.398M

TTM

Current Assets

$1.297M

Q2 2022

Current Liabilities

$6.114M

Q2 2022

Current Ratio

21.22%

Q2 2022

Total Assets

$14.91M

Q2 2022

Total Liabilities

$7.287M

Q2 2022

Book Value

$7.621M

Q2 2022

Cash

$253.4K

Q2 2022

P/E

-0.02509

Nov 29, 2024 EST

Free Cash Flow

-$855.4K

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Revenue	$1.600M	$30.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	5233.33%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Revenue	$1.600M	$30.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Cost Of Revenue	$1.420M	$20.00K
Gross Profit	$180.0K	$0.00
Gross Profit Margin	11.25%	0.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Selling, General & Admin	$2.130M	$3.630M	$540.0K	$50.00K	$0.00	$0.00	$40.00K	$40.00K	$40.00K	$50.00K	$50.00K	$70.00K	$90.00K	$60.00K	$0.00	$0.00
YoY Change	-41.32%	572.22%	980.0%			-100.0%	0.0%	0.0%	-20.0%	0.0%	-28.57%	-22.22%	50.0%
% of Gross Profit	1183.33%
Research & Development			$10.00K						$0.00	$0.00	$0.00	$0.00	-$10.00K	$30.00K	$30.00K	$80.00K
YoY Change												-100.0%	-133.33%	0.0%	-62.5%
% of Gross Profit
Depreciation & Amortization	$50.00K	$0.00	$0.00
YoY Change
% of Gross Profit	27.78%
Operating Expenses	$2.120M	$3.640M	$550.0K	$50.00K	$0.00	$0.00	$40.00K	$42.13K	$0.00	$0.00	$50.00K	$70.00K	$80.00K	$90.00K	$30.00K	$80.00K
YoY Change	-41.76%	561.82%	1000.0%			-100.0%	-5.06%			-100.0%	-28.57%	-12.5%	-11.11%	200.0%	-62.5%
Operating Profit	-$1.940M	-$3.640M
YoY Change	-46.7%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Interest Expense	-$5.680M	-$1.310M	-$10.00K	-$40.00K	-$10.00K	-$10.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$10.00K	$0.00
YoY Change	333.59%	13000.0%	-75.0%	300.0%	0.0%								-100.0%
% of Operating Profit
Other Income/Expense, Net	-$450.0K	-$40.00K	$0.00					$1.707K	$0.00	$0.00
YoY Change	1025.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Pretax Income	-$8.120M	-$4.930M	-$390.0K	-$90.00K	-$10.00K	-$10.00K	-$50.00K	-$50.00K	-$40.00K	-$50.00K	-$50.00K	-$70.00K	-$80.00K	-$90.00K	-$30.00K	-$80.00K
YoY Change	64.71%	1164.1%	333.33%	800.0%	0.0%	-80.0%	0.0%	25.0%	-20.0%	0.0%	-28.57%	-12.5%	-11.11%	200.0%	-62.5%
Income Tax				$0.00				$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.830M	-$4.930M	-$390.0K	-$90.00K	-$10.00K	-$10.00K	-$50.00K	-$50.00K	-$43.44K	-$53.78K	-$48.92K	-$70.13K	-$77.59K	-$84.64K	-$27.41K	-$82.74K
YoY Change	58.82%	1164.1%	333.33%	800.0%	0.0%	-80.0%	0.0%	15.1%	-19.22%	9.94%	-30.25%	-9.62%	-8.32%	208.83%	-66.88%
Net Earnings / Revenue	-489.38%	-16433.33%
Basic Earnings Per Share									$0.00	$0.00
Diluted Earnings Per Share	-$134.3K	-$288.3K	-$31.81K	-$11.98K	-$2.786K	-$2.786K	-$13.93K	-$13.93K	-$11.14K	-$13.93K	-$13.93K	-$19.50K	-$22.28K	-$25.07K	-$8.357K	-$22.28K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
Cash & Short-Term Investments	$30.00K	$0.00	$150.0K	$0.00	$0.00	$10.00K	$10.00K	$50.00K	$20.00K	$70.00K	$120.0K	$170.0K	$240.0K	$330.0K	$400.0K	$0.00
YoY Change		-100.0%			-100.0%	0.0%	-80.0%	150.0%	-71.43%	-41.67%	-29.41%	-29.17%	-27.27%	-17.5%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets	$10.00K							$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Inventory	$190.0K	$80.00K	$0.00
Prepaid Expenses
Receivables	$210.0K
Other Receivables	$0.00
Total Short-Term Assets	$440.0K	$80.00K	$150.0K	$0.00	$0.00	$10.00K	$10.00K	$50.00K	$20.00K	$70.00K	$120.0K	$170.0K	$240.0K	$330.0K	$400.0K	$0.00
YoY Change	450.0%	-46.67%			-100.0%	0.0%	-80.0%	150.0%	-71.43%	-41.67%	-29.41%	-29.17%	-27.27%	-17.5%
Property, Plant & Equipment	$850.0K	$30.00K	$10.00K
YoY Change	2733.33%	200.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$650.0K	$1.710M
YoY Change	-61.99%
Other Assets	$10.00K	$10.00K	$10.00K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$10.90M	$2.250M	$60.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	384.44%	3650.0%
Total Assets	$11.34M	$2.330M	$210.0K	$0.00	$0.00	$10.00K	$10.00K	$50.00K	$20.00K	$70.00K	$120.0K	$170.0K	$240.0K	$330.0K	$400.0K	$0.00
YoY Change
Accounts Payable	$730.0K	$230.0K	$90.00K	$20.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$10.00K	$0.00	$0.00	$140.0K
YoY Change	217.39%	155.56%	350.0%									-100.0%			-100.0%
Accrued Expenses	$280.0K	$30.00K	$10.00K	$30.00K	$20.00K	$10.00K	$10.00K						$0.00	$10.00K
YoY Change	833.33%	200.0%	-66.67%	50.0%	100.0%	0.0%							-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$1.720M	$2.370M	$50.00K	$90.00K	$70.00K	$70.00K	$70.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-27.43%	4640.0%	-44.44%	28.57%	0.0%	0.0%
Long-Term Debt Due	$980.0K
YoY Change
Total Short-Term Liabilities	$8.750M	$3.760M	$150.0K	$140.0K	$90.00K	$90.00K	$80.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$10.00K	$10.00K	$0.00	$140.0K
YoY Change	132.71%	2406.67%	7.14%	55.56%	0.0%	12.5%						-100.0%	0.0%		-100.0%
Long-Term Debt	$670.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$70.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change							-100.0%
Other Long-Term Liabilities	$560.0K							$0.00
YoY Change
Total Long-Term Liabilities	$1.230M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$70.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change							-100.0%
Total Liabilities	$13.55M	$3.760M	$150.0K	$140.0K	$90.00K	$90.00K	$80.00K	$80.00K	$0.00	$0.00	$0.00	$0.00	$10.00K	$10.00K	$0.00	$140.0K
YoY Change	260.37%	2406.67%	7.14%	55.56%	0.0%	12.5%	0.0%					-100.0%	0.0%		-100.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2013	2012
Basic Shares Outstanding	53.86M shares	53.86M shares
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $85.231 Thousand

About CANNABIS GLOBAL, INC.

Cannabis Global, Inc. operates as a cannabinoid and hemp extract science-forward company that develops infusion and delivery technologies. The company is headquartered in Los Angeles, California and currently employs 3 full-time employees. The company went IPO on 2008-06-19. The firm is engaged in developing the Ethos Comply Bag and conducts research and development in the areas of hemp, cannabis, and consumer food goods. The company operates and manages Natural Plant Extract of California, Inc. (NPE) which holds two active California cannabis licenses: a Type 7 manufacturing license and a distribution license. These licenses allow NPE to distribute cannabis products in the State of California. These products included several types of cannabis products, including Cannabis flower packaged in various weights, which are sold to California licensed cannabis retailers and distributors; cannabis pre-rolls, which are sold to California licensed cannabis retailers and distributors, and cannabis edible products, which are sold to California licensed cannabis retailers and distributors.

Industry: Biological Products, (No Diagnostic Substances) Peers: ACURA PHARMACEUTICALS, INC CANNABIS STRATEGIC VENTURES RespireRx Pharmaceuticals Inc. Rebus Holdings, Inc. JOHNSON & JOHNSON